{"id":"W1822242684","doi":"10.14740/cr413w","title":"Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban","year":2015,"lang":"en","type":"review","venue":"Cardiology Research","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Bayer Canada","keywords":"Rivaroxaban; Medicine; Dabigatran; Apixaban; Edoxaban; Deep vein; Warfarin; Pulmonary embolism; Atrial fibrillation; Stroke (engine); Vitamin K antagonist; Thrombosis; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004057938,0.0006680647,0.002353103,0.002719255,0.0003897568,0.002247618,0.000926961,0.002292921,0.00483531],"category_scores_gemma":[0.005689227,0.000329423,0.001473502,0.003522963,0.0009451002,0.003940871,0.001182978,0.002956407,0.0007381809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001401252,"about_ca_system_score_gemma":0.004420097,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001512369,"about_ca_topic_score_gemma":0.003689336,"domain_scores_codex":[0.9982717,0.0005752298,0.0003744138,0.0001501811,0.0005358654,0.00009257082],"domain_scores_gemma":[0.9943746,0.00386717,0.0007709345,0.00008531705,0.0007324491,0.0001694901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001202653,0.00004911779,0.0004001503,0.09160113,0.0004537948,0.000278812,0.0003050219,0.0002957909,0.0005475181,0.008705264,0.03639024,0.8608529],"study_design_scores_gemma":[0.00008675105,0.0001657521,0.00284896,0.09006133,0.00122914,0.00254678,0.001049255,0.0002964941,0.0002265126,0.01208893,0.8893367,0.0000633165],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009590224,0.9967151,0.0000496188,0.002657823,0.0002290765,0.000001985036,0.00000937912,0.00000229829,0.0002388365],"genre_scores_gemma":[0.0009892107,0.9973536,0.0001517002,0.00105478,0.0003258509,0.000004148475,0.00001575438,0.000001184638,0.0001038181],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00483531,"threshold_uncertainty_score":0.02146071,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4274711732967726,"score_gpt":0.5269145850990976,"score_spread":0.09944341180232497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}